NOV 18, 2017 7:10 AM PST

Genetically Modified Stem Cells Can Regenerate Whole Body Skin

WRITTEN BY: Courtney Schaal

Stem cell and gene therapies have been a topic of intrigue for years for a variety of indications ranging from disease treatment and organ regeneration, to cosmetic and beauty use. To date, barriers still remain to implementing such therapies in practice. In a recent article which was published in the November issue of Nature title Regeneration of the Entire Human Epidermis Using Transgenic Stem Cells, a team of scientists based out of Europe demonstrated the successful use of genetically engineered or modified stem cells to regenerate not just a patch of skin, but the entire human epidermis to treat a child with a severe and often lethal skin blistering disease, known as junctional epidermolysis bullosa (JEB). In this disease, patients harbor mutations in genes which encode for proteins necessary for skin structure and anchoring, including LAMA3, LAMB3, or LAMC2 as well as genes encoding for collagen, laminins, and integrins. Mutant forms of these proteins results in a fragile skin state and inability to heal in response to even minor trauma, so blistering and erosion of the skin and mucosa is not only common in those with this disease, but additionally leads to recurrent infections and scars, decreases the patients quality of life, and predisposes them to skin cancer. Currently, there is no cure for JEB.

Previously, scientists have been able to generate small areas of functional skin to help improve this condition, but with its widespread effects on the body small areas just aren’t enough. In this breakthrough study, the authors demonstrate the ability to regenerate skin across nearly the entire human body in a young child suffering from JEB for the first time. So how did they accomplish this?? Using gene therapy, and modifying a patient’s own cells. In this case, their patient was a seven year old child who had JEB. They obtained a biopsy of keratinocytes from this patient, taken from a region of normal, un-blemished skin which contained a subpopulation of epidermal stem cells capable of self-renewal and giving rise to progeny. Using the entire cell population from the biopsy, the researchers re-introduced a functional form of the gene LAMB3 which was mutated in this patients diseased cells, using retro-viral transduction. This allows for the retro-virus to integrate into the biopsied cells and express these non-mutant LAMB3 stably, and the cells can then be expanded for whole body use. After cultivation of these cells, they were grafted back onto affected areas of the patient, and after only a short period of engraftment epidermal regeneration was stable and complete, eventually covering roughly 80% of the affected areas body-wide. 21 months later, the patient maintains a stable, engrafted epidermis that now has the ability to regenerate after stress and that no longer blister. The researchers also demonstrated that the stem cell subpopulation of the graft were the only cells capable of persisting over time and continue to self-renew and maintain this healthy, engrafted population in the patient. This represents a breakthrough for patients with JEB and other similar skin disease caused by underlying genetic mutations.

Sources: Nature.com, Pixabay

About the Author
You May Also Like
MAY 16, 2020
Cannabis Sciences
MAY 16, 2020
Body's Own Cannabis Helps Us Forget Traumatic Events
Researchers have found that anandamide, often referred to as the body’s own cannabis, may help us forget traumatic ...
MAY 18, 2020
Cancer
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
JUN 12, 2020
Technology
JUN 12, 2020
How A Computer Sea Slug Can Get Addicted To A Drug
Sea slugs have long been used to study brain models especially in research concerned with memory and learning. Now, rese ...
JUN 24, 2020
Drug Discovery & Development
JUN 24, 2020
Gilead to Test Inhalable Remdesivir Against COVID-19
Gilead has announced that it will soon start trials for an inhalable form of Remdesivir, the first drug to receive Emerg ...
JUN 25, 2020
Drug Discovery & Development
JUN 25, 2020
Three New Molecular Targets for Epilepsy
A study lead by scientists at FutureNeuro discovered three new drugs hold the potential for targeting epilepsy. These dr ...
JUL 05, 2020
Microbiology
JUL 05, 2020
Stimulating Antibiotic Production in Bacteria
The microorganisms of the world have to compete for survival, and they sometimes do battle with one another. Some use an ...
Loading Comments...